Replies to post #440898 on Amarin Corp Plc (AMRN)

[Whalatane]

Good to see your posts again Laurent
re

Another thing to note is that Reduce-IT CKM (Kidney Metabolic Syndrome) event lines seem remarkably similar to PISCES event lines.

Yep ...Wife ( Nephrology PA ) noticed same thing .
She see's mostly dialysis patients and as noted in a previous post some of the benefit ...especially of the high EPA content ...may be in reducing endothelial cell damage around the fistulas . This damage causes an increase in clotting and plaque formation .

They were taking about how to replicate the EPA/DHA ratio used in the dialysis trial because apparently that exact EPA/DHA combo is not available in the US .

You would think some kind of Real World study could be initiated with matched profiles
Dialysis patients on Vascepa ( they usually only use FDA approved meds ...no supplements )
Dialysis patients on the EPA/DHA used in the PISCES trial
Dialysis patients on current SOC


Kiwi